Imagine trying to fix a leaky pipe without actually touching it, using sound waves instead. This technology uses a tiny ultrasound tool to clear up irregular heartbeats without needing the device to press firmly against the heart wall. It also acts like a built-in camera, letting doctors see exactly what is happening in real-time to ensure the treatment is precise.
Current AFib ablation depends on consistent physical contact with heart tissue and lacks real-time imaging, making the outcome highly dependent on the physician's individual skill.
A miniature-transcatheter ultrasound system that separates ablation and imaging modalities for contactless tissue treatment and real-time monitoring.
If you are a catheter manufacturer dealing with the limitations of contact-dependent ablation — this project developed a contactless ultrasound-based approach that provides real-time tissue monitoring. This allows for safer procedures and higher accuracy in treating AFib.
If you are a clinic dealing with high variability in physician skill for AFib treatment — this project developed a dual-mode ultrasound system that reduces dependence on manual contact. This improves patient outcomes by providing real-time imaging of the lesion.
If you are an investor dealing with high-risk early-stage medical assets — this project developed a proprietary ultrasound technology transitioning from preclinical to clinical studies. It is backed by a team with over 1B in previous exits.
The project is leveraging an EC investment of 12.75M to demonstrate efficacy, safety, and establish a manufacturing line.
The project is currently focused on the transition from preclinical to clinical studies and establishing a manufacturing line.
The project is based on proprietary ultrasound technology developed by Healium Medical Ltd.
A key objective of the project is to establish a regulatory framework to enable market access as a self-sustained company.
The project period runs from 2022-09-01 to 2025-08-31.
The project is led by a single SME, Healium Medical Ltd from Israel, representing a 100% industry ratio. This lean structure suggests a fast-track commercialization path, supported by a leadership team with significant medical entrepreneurship experience and a history of high-value exits.
Contact Healium Medical Ltd regarding their ultrasound-based ablation clinical trials.
Contact us to explore licensing opportunities for contactless ultrasound ablation.
